Cited by 11Liver physiology and pathologyLiver Diseases and ImmunityTGF-β signaling in diseases

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Mechanism of TGF‑β1 inhibiting Kupffer cell immune responses in cholestatic cirrhosis

Open access
Qian, Jun, Jiao, Yuwen, Wang, Guangyao, Liu, Hanyang, Cao, Xiang, Yang, Haojun·2020·Experimental and Therapeutic Medicine

Abstract

Effect of exogenous transforming growth factor-β1 (TGF-β1) on cholestatic mice by inhibiting Kupffer cell immune responses in liver was investigated. To induce cholestasis, BALB/c mice received a sham operation (Mock group), or underwent a bile duct ligation (BDL group) and then were subcutaneously injected with TGF-β1 at multiple sites (TGF group). Liver functions were evaluated according to the levels of alanine aminotransferase (ALT), aspartate aminotransferase AST and γ-glutamyltranspeptidase (γ-GT) in serum samples. Expression of nuclear factor-κB (NF-κB), interleukin-6 (IL-6), IL-1β and tumor necrosis factor-α (TNF-α) was detected. Expression of inducible nitric oxide synthase (iNOS) and arginase-1 (Arg-1) in Kupffer cells (KCs) of the liver was detected. The isolated KCs were divided into control group, LPS group, TGF group and Galunisertib group and western blot analysis was used to detect the expression of NF-κB, IL-6, IL-1β, TNF-α, iNOS and Arg-1. The percentage of CD40, CD86, CD204 and CD206 as macrophage cell surface antigens were measured by flow cytometry. The indexes of liver function and liver fibrosis of the mice in the TGF group were significantly lower than those in the BDL group (P<0.05). The levels of IL-1β, IL-6 and TNF-α in the liver were lower than those in the BDL group, while the level of IL-10 was significantly increased (P<0.05). M2-type transformation occurred in liver Kupffer cells of mice in the TGF group. In cell experiments, TGF treatment downregulated the expression of IL-1β, IL-6, TNF-α and NF-κB, increased the expression of IL-10, and induced M2-type transformation in macrophages (P<0.05). In conclusion, TGF-ß1 diminished the progression of cholestasis in mice by inhibiting the inflammatory response of KCs and regulating KC polarization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/etm.2020.8826

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TGF-β1 administration reduces fibrosis in a BDL model by promoting macrophage polarization toward a restorative phenotype.

    “Interestingly, although transforming growth factor-β1 (TGF-β1) is a central driver of fibrogenesis, its administration reduced fibrosis in a BDL model by promoting macrophage polarization toward a restorative phenotype (126).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 50

  1. [1]Zakharia K Tabibian A Lindor KD Tabibian JH Complications, symptoms, quality of life and pregnancy in cholestatic liver disease Liver Int 38 399 411 2018 10.1111/liv.13591 28921801 · DOI · Paper page
  2. [2]Zhao S Li N Zhen Y Ge M Li Y Yu B He H Shao RG Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats Food Chem Toxicol 86 202 207 2015 10.1016/j.fct.2015.10.010 26498411 · DOI
  3. [3]Seca AM Pinto DC Plant secondary metabolites as anticancer agents: Successes in clinical trials and therapeutic application Int J Mol Sci 19 19 2018 10.3390/ijms19010263 29337925 PMC5796209 · DOI
  4. [4]Miyaguchi S Ebinuma H Imaeda H Nitta Y Watanabe T Saito H Ishii H A novel treatment for refractory primary biliary cirrhosis? Hepatogastroenterology 47 1518 1521 2000 11148991
  5. [5]Drivdal M Holven KB Retterstøl K Aagenaes Ø Kase BF A nine year follow-up study of patients with lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome) Scand J Clin Lab Invest 78 566 574 2018 10.1080/00365513.2018.1519723 30755100 · DOI
  6. [6]Paquissi FC Immunity and fibrogenesis: The role of Th17/IL-17 axis in HBV and HCV-induced chronic hepatitis and progression to cirrhosis Front Immunol 8 1195 2017 10.3389/fimmu.2017.01195 29033929 PMC5626935 · DOI
  7. [7]Burnevich ES Popova EN Ponomarev AB Nekrasova TP Lebedeva MV Filatova AL Shchanitcyna EM Ponomareva LA Beketov VD Bondarenko IB Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review) Ter Arkh 91 89 94 2019 10.26442/00403660.2019.01.000036 31090378 · DOI
  8. [8]Zhu J Wang R Xu T Zhang S Zhao Y Li Z Wang C Zhou J Gao D Hu Y Salvianolic acid a attenuates endoplasmic reticulum stress and protects against cholestasis-induced liver fibrosis via the SIRT1/HSF1 pathway Front Pharmacol 9 1277 2018 10.3389/fphar.2018.01277 30455644 PMC6230567 · DOI
  9. [9]Mohammadi A Blesso CN Barreto GE Banach M Majeed M Sahebkar A Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent J Nutr Biochem 66 1 16 2019 10.1016/j.jnutbio.2018.12.005 30660832 · DOI
  10. [10]Cheng Z Zhou YZ Wu Y Wu QY Liao XB Fu XM Zhou XM Diverse roles of macrophage polarization in aortic aneurysm: Destruction and repair J Transl Med 16 354 2018 10.1186/s12967-018-1731-0 30545380 PMC6293547 · DOI
  11. [12]Gong W, Huang F, Sun L, Yu A, Zhang X, Xu Y, Shen Y and Cao J: Toll-like receptor-2 regulates macrophage polarization induced by excretory-secretory antigens from Schistosoma japonicum eggs and promotes liver pathology in murine schistosomiasis. PLoS Negl Trop Dis: Dec 27, 2018 (Epub ahead of print). doi: 10.1371/journal.pntd.0007000.. PMC6307705 30589840 · DOI
  12. [13]Cho U Kim B Kim S Han Y Song YS Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation Mol Carcinog 57 235 242 2018 10.1002/mc.22750 29024042 · DOI
  13. [14]Wang Y Smith W Hao D He B Kong L M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds Int Immunopharmacol 70 459 466 2019 10.1016/j.intimp.2019.02.050 30861466 · DOI
  14. [15]Qing L Fu J Wu P Zhou Z Yu F Tang J Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK/mTOR/NLRP3 inflammasome singling pathway Am J Transl Res 11 655 668 2019 30899369 PMC6413292
  15. [16]Wang Y Guo X Jiao G Luo L Zhou L Zhang J Wang B Splenectomy promotes macrophage polarization in a mouse model of concanavalin A- (ConA-) induced liver fibrosis BioMed Res Int 2019 5756189 2019 10.1155/2019/5756189 30723740 PMC6339718 · DOI
  16. [17]Lu CH, Lai CY, Yeh DW, Liu YL, Su YW, Hsu LC, Chang CH, Catherine Jin SL and Chuang TH: Involvement of M1 macrophage polarization in endosomal Toll-like receptors activated psoriatic inflammation. Mediators Inflamm: Dec 16, 2018 (Epub ahead of print). doi: 10.1155/2018/3523642. PMC6311781 30647534 · DOI
  17. [18]Tsuneyama K Harada K Kono N Hiramatsu K Zen Y Sudo Y Gershwin ME Ikemoto M Arai H Nakanuma Y Scavenger cells with gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis J Hepatol 35 156 163 2001 10.1016/s0168-8278(01)00084-8 11580136 · DOI
  18. [19]Prunier C Baker D Ten Dijke P Ritsma L TGF-β family signaling pathways in cellular dormancy Trends Cancer 5 66 78 2019 10.1016/j.trecan.2018.10.010 30616757 · DOI
  19. [20]Dragotto J Canterini S Del Porto P Bevilacqua A Fiorenza MT The interplay between TGF-β-stimulated TSC22 domain family proteins regulates cell-cycle dynamics in medulloblastoma cells J Cell Physiol 234 18349 18360 2019 10.1002/jcp.28468 30912127 · DOI
  20. [22]Dropmann A Dediulia T Breitkopf-Heinlein K Korhonen H Janicot M Weber SN Thomas M Piiper A Bertran E Fabregat I TGF-β1 and TGF-β2 abundance in liver diseases of mice and men Oncotarget 7 19499 19518 2016 10.18632/oncotarget.6967 26799667 PMC4991397 · DOI
  21. [23]Li MO Wan YY Sanjabi S Robertson AK Flavell RA Transforming growth factor-beta regulation of immune responses Annu Rev Immunol 24 99 146 2006 10.1146/annurev.immunol.24.021605.090737 16551245 · DOI
  22. [25]Tang J Gifford CC Samarakoon R Higgins PJ Deregulation of negative controls on TGF-β1 signaling in tumor progression Cancers (Basel) 10 10 2018 10.3390/cancers10060159 29799477 PMC6025439 · DOI
  23. [26]Zeng WQ Zhang JQ Li Y Yang K Chen YP Liu ZJ A new method to isolate and culture rat kupffer cells PLoS One 8 e70832 2013 10.1371/journal.pone.0070832 23967115 PMC3743898 · DOI
  24. [27]Mishra B Tang Y Katuri V Fleury T Said AH Rashid A Jogunoori W Mishra L Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis Liver Int 24 637 645 2004 10.1111/j.1478-3231.2004.0958.x 15566516 · DOI
  25. [28]Neuman M Angulo P Malkiewicz I Jorgensen R Shear N Dickson ER Haber J Katz G Lindor K Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis J Gastroenterol Hepatol 17 196 202 2002 10.1046/j.1440-1746.2002.02672.x 11966951 · DOI
  26. [29]Martinez OM Villanueva JC Gershwin ME Krams SM Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis Hepatology 21 113 119 1995 7806143
  27. [30]Liu B Zhang X Zhang FC Zong JB Zhang W Zhao Y Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model World J Gastroenterol 19 5828 5836 2013 10.3748/wjg.v19.i35.5828 24124327 PMC3792337 · DOI
  28. [31]Hasan MS Karim AB Rukunuzzaman M Haque A Akhter MA Shoma UK Yasmin F Rahman MA Rahman MA Role of liver biopsy in the diagnosis of neonatal cholestasis due to biliary atresia Mymensingh Med J 27 826 833 2018 30487501
  29. [32]Houwen R Chapter 6.4. Diagnostic Progress in Cholestasis J Pediatr Gastroenterol Nutr 66 (Suppl 1) S134 S136 2018 10.1097/MPG.0000000000001916 29596185 · DOI
  30. [33]Trauner M Meier PJ Boyer JL Molecular pathogenesis of cholestasis N Engl J Med 339 1217 1227 1998 10.1056/NEJM199810223391707 9780343 · DOI
  31. [34]Virani S Akers A Stephenson K Smith S Kennedy L Alpini G Francis H Comprehensive review of molecular mechanisms during cholestatic liver injury and cholangiocarcinoma J Liver 7 7 2018 10.4172/2167-0889.1000231 30613437 PMC6319937 · DOI
  32. [35]Cies JJ Giamalis JN Treatment of cholestatic pruritus in children Am J Health Syst Pharm 64 1157 1162 2007 10.2146/ajhp060453 17519457 · DOI
  33. [36]Hirschfield GM Heathcote EJ Cholestasis and cholestatic syndromes Curr Opin Gastroenterol 25 175 179 2009 10.1097/mog.0b013e32832914b4 19396955 · DOI
  34. [37]Sun X Xie Z Ma Y Pan X Wang J Chen Z Shi P TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling J Cell Physiol 233 596 606 2018 10.1002/jcp.25920 28322449 · DOI
  35. [38]Hu B Xu C Cao P Tian Y Zhang Y Shi C Xu J Yuan W Chen H TGF-β stimulates expression of chondroitin polymerizing factor in nucleus pulposus cells through the Smad3, RhoA/ROCK1, and MAPK signaling pathways J Cell Biochem 119 566 579 2018 10.1002/jcb.26215 28608941 · DOI
  36. [39]Du M Chen W Zhang W Tian XK Wang T Wu J Gu J Zhang N Lu ZW Qian LX TGF-β1 regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma Biomed Pharmacother 99 688 696 2018 10.1016/j.biopha.2018.01.120 29710466 · DOI
  37. [40]Coppola N Zampino R Sagnelli C Bellini G Marrone A Stanzione M Capoluongo N Boemio A Minichini C Adinolfi LE Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C PLoS One 9 e99450 2014 10.1371/journal.pone.0099450 24940753 PMC4062424 · DOI
  38. [41]Mazzella G Salzetta A Casanova S Morelli MC Villanova N Miniero R Sottili S Novelli V Cipolla A Festi D Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: Gamma GT levels predictive for response Dig Dis Sci 39 866 870 1994 10.1007/BF02087435 7908624 · DOI
  39. [42]Van Campenhout S Van Vlierberghe H Devisscher L Common bile duct ligation as model for secondary biliary cirrhosis Methods Mol Biol 1981 237 247 2019 10.1007/978-1-4939-9420-5_15 31016658 · DOI
  40. [43]Lotowska JM Sobaniec-Lotowska ME Lebensztejn DM Daniluk U Sobaniec P Sendrowski K Daniluk J Reszec J Debek W Festi D Ultrastructural characteristics of rat hepatic oval cells and their intercellular contacts in the model of biliary fibrosis: New insights into experimental liver fibrogenesis Gastroenterol Res Pract 2017 2721547 2017 10.1155/2017/2721547 28769978 PMC5523291 · DOI
  41. [44]Liu TZ Lee KT Chern CL Cheng JT Stern A Tsai LY Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB Ann Clin Lab Sci 31 383 390 2001 11688850
  42. [45]Huang ZH Huang X Li Y Changes and significance of tumor necrosis factor-alpha and interleukin-6 level in plasma and bile during the formation of acute intrahepatic cholestasis in New Zealand white rabbits Zhonghua Gan Zang Bing Za Zhi 11 313 2003 (In Chinese) 12773254
  43. [46]Sen R Baltimore D Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappaB by a posttranslational mechanism Cell 47 921 928 1986 3096580
  44. [47]Ghosh S Hayden MS New regulators of NF-kappaB in inflammation Nat Rev Immunol 8 837 848 2008 10.1038/nri2423 18927578 · DOI
  45. [48]Editors PO PLOS ONE Editors: Expression of Concern: The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells PLoS One 14 e0216434 2019 10.1371/journal.pone.0216434 31039198 PMC6490955 · DOI
  46. [49]Park J Ha SH Abekura F Lim H Magae J Ha KT Chung TW Chang YC Lee YC Chung E 4-O-carboxymethyl ascochlorin inhibits expression levels of on inflammation-related cytokines and matrix metalloproteinase-9 through NF-κB/MAPK/TLR4 signaling pathway in LPS-activated RAW264.7 cells Front Pharmacol 10 304 2019 10.3389/fphar.2019.00304 31001118 PMC6445864 · DOI
  47. [50]van der Tuin SJ Li Z Berbée JF Verkouter I Ringnalda LE Neele AE van Klinken JB Rensen SS Fu J de Winther MP Lipopolysaccharide lowers cholesteryl ester transfer protein by activating F4/80+Clec4f+Vsig4+Ly6C- Kupffer cell subsets J Am Heart Assoc 7 7 2018 10.1161/JAHA.117.008105 29525783 PMC5907564 · DOI
  48. [51]Feng P Zhu W Chen N Li P He K Gong J Cathepsin B in hepatic Kupffer cells regulates activation of TLR4-independent inflammatory pathways in mice with lipopolysaccharide-induced sepsis Nan Fang Yi Ke Da Xue Xue Bao 38 1465 1471 2018 (In Chinese) 10.12122/j.issn.1673-4254.2018.12.11 30613015 PMC6744205 · DOI
  49. [52]Zhang WJ Fang ZM Liu WQ NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-κB Parasit Vectors 12 29 2019 10.1186/s13071-018-3223-8 30635040 PMC6330481 · DOI
  50. [53]Ohtani N Kawada N Role of the gut-liver axis in liver inflammation, fibrosis, and cancer: A special focus on the gut microbiota relationship Hepatol Commun 3 456 470 2019 10.1002/hep4.1331 30976737 PMC6442695 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Qian, J., Jiao, Y., Wang, G., Liu, H., Cao, X., & Yang, H.
Affiliations
Changzhou No.2 People's Hospital (CN)
Corresponding author
Yang, Haojun
Venue
Experimental and Therapeutic Medicine
Published
2020-05-30
Volume
20
Issue
2
Pages
1541-1549
ISSN
  • 1792-0981 (ISSN-L)
  • 1792-1015
OpenAlex
W3032701030
Cited by
11
References
3
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 1
FWCI
0.44
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Experimental and Therapeutic Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
TGF-β1, Kupffer cells, cholestatic cirrhosis, bile duct ligation, M2 macrophage polarization, liver inflammation, NF-κB, IL-10, interleukin-6, TNF-α, inducible nitric oxide synthase, arginase-1, liver fibrosis, galunisertib

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review